Profound Medical Corp. is a commercial-stage medical device company focused on developing and marketing incision-free therapeutic systems for image-guided ablation of diseased tissue. Its flagship TULSA-PRO system combines real-time MRI, AI-assisted planning, robotically driven transurethral ultrasound, and closed-loop temperature control to treat prostate tissue with precision. The company also offers Sonalleve, an MRI-guided focused ultrasound platform designed for noninvasive treatment of diseased tissue. Profound Medical Corp. serves hospitals and specialty medical centers that use its technologies in urology and other therapeutic applications, with a business model centered on device sales, associated disposable components, and clinical support services. Headquartered in Mississauga, Canada, Profound Medical Corp. plays a niche role in the medical technology market by providing minimally invasive alternatives that integrate with existing imaging infrastructure.
Website2400 Skymark Avenue
Mississauga, ON, L4W 5K5
Canada
Detailed price information for Profound Medical Corp (PRN-T) from The Globe and Mail including charting and trades.
Profound Medical (PRN.TO) appointed Richard Fabian as its new president, effective immediately, the
Profound Medical (PROF) said Tuesday it appointed Richard Fabian as president, effective immediately
TORONTO, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, today announced the promotion of Matthew Sobczyk from Corporate Controller to Interim Chief Financial Officer, effective immediately. Mr. Sobczyk, who first joined Profound in 2020, succeeds Rashed Dewan, who has stepped down as the Company’s Chief Financial Offi
Investors talking about PROF also mention
| # | Name | Attention |
|---|---|---|
| 1 | Edap Tms S.A.EDAP | 0%0 |
| 2 | TransMedics Group, Inc.TMDX | 0%-0.01 |
| 3 | Pavmed Inc.PAVM | 0%0 |
| 4 | RedHill Biopharma Ltd. American Depositary SharesRDHL | 0%0 |
| 5 | AbCellera Biologics Inc.ABCL | 0.24%-0.06 |
| 6 | Ouster, Inc.OUST | 0.03%+0 |
| 7 | MYOV - Myovant Sciences Ltd. | —— |
| 8 | Wave Life Sciences Ltd.WVE | 0%+0 |
| 9 | Axsome Therapeutics IncAXSM | 0.01%0 |
| 10 | CVS Health CorporationCVS | 0%0 |
What share of all stock conversation is about PROF?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% 0 | 0% 0 | 0% 0 | 0% 0 |
Of the messages about PROF that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | — | — | 93.2% -6.8 | ||
| Bearish | — | — | — | 6.8% +6.8 |
Of the messages about PROF that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Analysts | — | — | 100% | 7.6% | ||
| Announcements | — | — | 0% | 67.25% | ||
| Controversies | — | — | 0% | 0% | ||
| Earnings | — | — | 0% | 15.79% | ||
| Macro | — | — | 0% | 7.02% | ||
| Technical Analysis | — | — | 0% | 2.34% |
Of the messages about PROF, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | — | — | 100% | 22.75% | ||
| Newcomers | — | — | 0% | 77.25% |